GLP-1/glucagon co-agonism lowers liver fat more than GLP-1 but not glucagon mono-agonism in obese mice

被引：0
|
作者：
Winther-Sorensen, M. [1 ,2 ]
Rasmussen, C. [1 ]
Trammell, S. A. J. [3 ]
Serizawa, R. R. [4 ]
Vyberg, M. [4 ]
Richter, E. A. [5 ]
Grevengoed, T. [3 ]
Gluud, L. L. [6 ]
Kuhre, R. E. [7 ,8 ]
Albrechtsen, N. J. Wewer [1 ,2 ]
机构：
[1] Bispebjerg Hosp, Dept Clin Biochem, Copenhagen NV, Denmark
[2] Univ Copenhagen, NNF Ctr Prot Res, Copenhagen N, Denmark
[3] Univ Copenhagen, Dept Biomed Sci, Copenhagen N, Denmark
[4] Copenhagen Univ Hosp Hvidovre, Dept Pathol, Hvidovre, Denmark
[5] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark
[6] Copenhagen Univ Hosp Hvidovre, Gastro Unit, Hvidovre, Denmark
[7] Novo Nordisk, Dept Obes, Malov, Denmark
[8] Novo Nordisk, NASH Pharmacol, Malov, Denmark
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LBA 57
引用
收藏
页码：S536 / S536
页数：1
相关论文
共 50 条
  • [1] GLP-1/glucagon receptor co-agonism for treatment of obesity
    Sanchez-Garrido, Miguel A.
    Brandt, Sara J.
    Clemmensen, Christoffer
    Mueller, Timo D.
    DiMarchi, Richard D.
    Tschoep, Matthias H.
    DIABETOLOGIA, 2017, 60 (10) : 1851 - 1861
  • [2] GLP-1/glucagon receptor co-agonism for treatment of obesity
    Miguel A. Sánchez-Garrido
    Sara J. Brandt
    Christoffer Clemmensen
    Timo D. Müller
    Richard D. DiMarchi
    Matthias H. Tschöp
    Diabetologia, 2017, 60 : 1851 - 1861
  • [3] Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
    Hope, David C. D.
    Vincent, Matthew L.
    Tan, Tricia M. M.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [4] SYNTHESIS AND CHARACTERIZATION OF PEPTIDES WITH GLUCAGON ANTAGONISM AND GLP-1 AGONISM
    Ouyang, C.
    Yang, B.
    Gelfanov, V.
    Zhang, F.
    DiMarchi, R.
    BIOPOLYMERS, 2009, 92 (04) : 359 - 359
  • [5] GLP-1 and Glucagon Receptors Dual Agonism Exerts Superior Lipid Lowering Effects to GLP1R-selective Agonism in Obese Mice
    Lao, Julie Z.
    Cumiskey, Anne-Marie
    Stout, Steven
    Li, Wenyu
    Kowalik, Edward
    Szeto, Daphne
    Nawrocki, Andrea
    Sun, Ping
    Mclaren, David
    Murphy, Beth Ann
    Pocai, Alessandro
    Carrington, Paul E.
    DIABETES, 2014, 63 : A162 - A162
  • [6] Optimization of co-agonism at GLP-1 and glucagon receptors to safely maximize weight reduction in DIO-rodents
    Day, Jonathan W.
    Gelfanov, Vasily
    Smiley, David
    Carrington, Paul E.
    Eiermann, George
    Chicchi, Gary
    Erion, Mark D.
    Gidda, Jas
    Thornberry, Nancy A.
    Tschoep, Matthias H.
    Marsh, Donald J.
    SinhaRoy, Ranabir
    DiMarchi, Richard
    Pocai, Alessandro
    BIOPOLYMERS, 2012, 98 (05) : 443 - 450
  • [7] The current significance and prospects for the use of dual receptor agonism GLP-1/Glucagon
    Spezani, Renata
    Mandarim-de-Lacerda, Carlos Alberto
    LIFE SCIENCES, 2022, 288
  • [8] Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors
    Darbalaei, Sanaz
    Yuliantie, Elita
    Dai, Antao
    Chang, Rulue
    Zhao, Peishen
    Yang, Dehua
    Wang, Ming-Wei
    Sexton, Patrick M.
    Wootten, Denise
    BIOCHEMICAL PHARMACOLOGY, 2020, 180
  • [9] Vasodilator Effect of Glucagon: Receptorial Crosstalk Among Glucagon, GLP-1, and Receptor for Glucagon and GLP-1
    Selley, E.
    Kun, S.
    Szijarto, I. A.
    Kertesz, M.
    Wittmann, I.
    Molnar, G. A.
    HORMONE AND METABOLIC RESEARCH, 2016, 48 (07) : 476 - 483
  • [10] The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review
    Mathiesen, David S.
    Bagger, Jonatan I.
    Bergmann, Natasha C.
    Lund, Asger
    Christensen, Mikkel B.
    Vilsboll, Tina
    Knop, Filip K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (17)
12345